Monoclonal Antibody Treatments

Let’s Prevent Hospitalizations and Consider Monoclonal Antibody Treatments In November, 2020, FDA issued Emergency Use Authorizations (EUA) for two monoclonal antibody products. An EUA is different than full FDA approval in that it is issued in emergent circumstances, usually without the comprehensive studies required for full licensure of the product. Because of this limited data,…